IGF2BP3 and gastric adenocarcinoma: As IGF2BP2 and IGF2BP3 can maintain the stability of mRNAs in m6A modification process (30, 31), our result also indicated METTL14 can extend the half-life of PTEN mRNA in STAD cells.